Jazz Reports Phase 3 Success for Ziihera in HER2+ GEA
DUBLIN, Ireland, May 27, 2026 Jazz Pharmaceuticals has announced the publication of pivotal Phase 3 HERIZON-GEA-01 trial results in...
financial results
Advertisement
Innocan Pharma Reports Strong Q1 Growth and Pipeline Progress
HERZLIYA, Israel and CALGARY, Alberta, May 27, 2026 Innocan Pharma Corporation has reported strong first-quarter 2026 financial results, highlighting...
Elanco Sets Date for Q4 and Full-Year 2025 Results Call
Indianapolis, USA | January 22, 2026 — Elanco Animal Health, a global leader in veterinary pharmaceuticals and animal health...
Pelthos Therapeutics Reports Solid Q3 FY2025 Financial Results
SEATTLE, WA – November 13, 2025 — Pelthos Therapeutics released its third-quarter fiscal 2025 financial results, highlighting strong R&D...
Piramal Pharma Reports Q2 & H1 FY26 Results, Strengthens Global CDMO and Generics Capabilities
Dateline – Mumbai, India, November 5, 2025:Piramal Pharma Limited (NSE: PPLPHARMA, BSE: 543635), a leading global pharmaceutical, health and...
Advertisement
